[BrainQ in NoCamels] BrainQ Device To Reduce Disability Post-Stroke Gets FDA ‘Breakthrough’ Status
Israeli medtech company BrainQ, a developer of AI-powered technology to treat neuro disorders, announced on Thursday that the US Food and Drug Administration (FDA) has designated its AI-powered therapeutic solution to reduce disability following stroke, as a Breakthrough Device. Read more...
Read More